No Data
No Data
No Data
No Data
No Data
Eli Lilly Obesity Therapy Succeeds in Late-stage Trials for Sleep Disorder
Seeking AlphaApr 17 07:04 ET
GLP-1s Benefit Parkinson's: Barclays Sees Implications Across Biopharma
Seeking AlphaApr 12 12:02 ET
No Link Between Weight Loss Drugs and Suicidal Thoughts, EU Regulator Concludes
Seeking AlphaApr 12 07:05 ET
Ginkgo Bioworks Expands R&D Tie-up With Novo Nordisk
Seeking AlphaApr 10 07:34 ET
Weight-loss Drug Shortage Result of 'Unprecedented Demand'
Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own weight-loss treatment Wegovy.
Yahoo FinanceApr 8 17:35 ET
Novo's Ozempic to Face Copycats as Chinese Firm Seeks Approval for Biosimilar
Seeking AlphaApr 3 07:01 ET
JC7577 : nice
Kakakala12 : Should I get that one?
Salmon Klein : I like what I see and is not nvidia..
Cocona33 : AI stocks and APX are nice.$Appen Ltd (APX.AU)$
No Data
No Data
Mohamad Ebrahimi : سلام